Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced it has received final approval from the U.S. FDA for the Company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE